113 related articles for article (PubMed ID: 11697486)
1. LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells.
Lee IS; Shin YK; Chung DH; Park SH
Leuk Lymphoma; 2001 Aug; 42(4):587-94. PubMed ID: 11697486
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
Lee IS; Kim SH; Song HG; Park SH
Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
[TBL] [Abstract][Full Text] [Related]
3. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype.
Kim SH; Shin YK; Lee IS; Bae YM; Sohn HW; Suh YH; Ree HJ; Rowe M; Park SH
Blood; 2000 Jan; 95(1):294-300. PubMed ID: 10607715
[TBL] [Abstract][Full Text] [Related]
4. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2).
Kim SH; Choi EY; Shin YK; Kim TJ; Chung DH; Chang SI; Kim NK; Park SH
Blood; 1998 Dec; 92(11):4287-95. PubMed ID: 9834235
[TBL] [Abstract][Full Text] [Related]
5. CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Lee I; Kim MK; Choi EY; Mehl A; Jung KC; Gil MC; Rowe M; Park SH
Blood; 2001 Jun; 97(11):3596-604. PubMed ID: 11369656
[TBL] [Abstract][Full Text] [Related]
6. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma.
Chang KC; Chang Y; Jones D; Su IJ
Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233
[TBL] [Abstract][Full Text] [Related]
8. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Reynolds DJ; Banks PM; Gulley ML
Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
[TBL] [Abstract][Full Text] [Related]
9. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.
Lee EK; Chae JH; Kang MS
Mol Cells; 2011 Dec; 32(6):555-60. PubMed ID: 22083306
[TBL] [Abstract][Full Text] [Related]
11. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
[TBL] [Abstract][Full Text] [Related]
12. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
[TBL] [Abstract][Full Text] [Related]
13. SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.
Jian W; Zhong L; Wen J; Tang Y; Qiu B; Wu Z; Yan J; Zhou X; Zhao T
PLoS One; 2015; 10(5):e0127568. PubMed ID: 26000982
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
[TBL] [Abstract][Full Text] [Related]
15. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
[TBL] [Abstract][Full Text] [Related]
16. Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease.
Oudejans JJ; Jiwa NM; Kummer JA; Horstman A; Vos W; Baak JP; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
Blood; 1996 May; 87(9):3844-51. PubMed ID: 8611711
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.
Vockerodt M; Morgan SL; Kuo M; Wei W; Chukwuma MB; Arrand JR; Kube D; Gordon J; Young LS; Woodman CB; Murray PG
J Pathol; 2008 Sep; 216(1):83-92. PubMed ID: 18566961
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
20. Dual variant of Epstein-Barr virus in Hodgkin/Reed-Sternberg cells: single-cell PCR study on latent membrane protein-1 gene.
Kim LH; Peh SC; Poppema S
Int J Cancer; 2003 Nov; 107(2):250-5. PubMed ID: 12949802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]